Combining datasets as well as therapies shows improved outcome in connective tissue disease associated pulmonary hypertension

The article of Khanna et al [1] is an important summary of more than two decades of progress in management of connective tissue disease (CTD) associated pulmonary hypertension (PH) that provides an important platform for further advances. It also clearly shows the positive impact of current practice with combination therapy introduced early and an emphasis on proactive screening to make an early diagnosis of PH.